Clinical and Subtypes of Breast Cancer in Indonesia

Background: Breast cancer is still a global public health problem, especially in women and is the second leading cause of death after lung cancer. Indonesia is a country with a high incidence of breast among women. Methods: This study used a retrospective study of breast cancer patients registered...

Full description

Bibliographic Details
Main Authors: I Ketut Widiana, Hendry Irawan
Format: Article
Language:English
Published: West Asia Organization for Cancer Prevention 2020-12-01
Series:Asian Pacific Journal of Cancer Care
Subjects:
Online Access:http://www.waocp.com/journal/index.php/apjcc/article/view/550
_version_ 1797344313434177536
author I Ketut Widiana
Hendry Irawan
author_facet I Ketut Widiana
Hendry Irawan
author_sort I Ketut Widiana
collection DOAJ
description Background: Breast cancer is still a global public health problem, especially in women and is the second leading cause of death after lung cancer. Indonesia is a country with a high incidence of breast among women. Methods: This study used a retrospective study of breast cancer patients registered at Division of Surgical Oncology in Indonesia. Information about demographic, clinical and pathological characteristics of patients for a period of 5 years (2014 to 2020) were collected and described. Results: Information for 1260 cases of breast cancer who underwent IHC examination with an average age of 53.73 years of patients, with the most age above 50 years (63.6%) were collected. On IHC examination, 58.6% positive estrogen receptors were found, positive progesterone receptors were 55.4%, Her2 was positive 37.7% and high Ki67 protein was 56.9%. The most common breast cancer subtypes were luminal B (43.2%), followed by luminal A (21.7%), TNBC (18.1%), and Her2 (17%), with the highest stages being IIIB (31.7%). Conclusions: The breast cancer was presented at higher stage, with more cases with estrogen or progesterone receptors are positive with low frequency of Her2 positivity and high in Ki67 protein expression.
first_indexed 2024-03-08T11:00:35Z
format Article
id doaj.art-db458cdde6b54c80a52442b95b4d9563
institution Directory Open Access Journal
issn 2588-3682
language English
last_indexed 2024-03-08T11:00:35Z
publishDate 2020-12-01
publisher West Asia Organization for Cancer Prevention
record_format Article
series Asian Pacific Journal of Cancer Care
spelling doaj.art-db458cdde6b54c80a52442b95b4d95632024-01-26T16:05:03ZengWest Asia Organization for Cancer PreventionAsian Pacific Journal of Cancer Care2588-36822020-12-015428128510.31557/apjcc.2020.5.4.281-285550Clinical and Subtypes of Breast Cancer in IndonesiaI Ketut Widiana0Hendry Irawan1Surgical Oncology Division, Department of Surgery, Medical Faculty Udayana University, Sanglah General Hospital DenpasarSurgical Oncology Division, Department of Surgery, Medical Faculty Udayana University, Sanglah General Hospital DenpasarBackground: Breast cancer is still a global public health problem, especially in women and is the second leading cause of death after lung cancer. Indonesia is a country with a high incidence of breast among women. Methods: This study used a retrospective study of breast cancer patients registered at Division of Surgical Oncology in Indonesia. Information about demographic, clinical and pathological characteristics of patients for a period of 5 years (2014 to 2020) were collected and described. Results: Information for 1260 cases of breast cancer who underwent IHC examination with an average age of 53.73 years of patients, with the most age above 50 years (63.6%) were collected. On IHC examination, 58.6% positive estrogen receptors were found, positive progesterone receptors were 55.4%, Her2 was positive 37.7% and high Ki67 protein was 56.9%. The most common breast cancer subtypes were luminal B (43.2%), followed by luminal A (21.7%), TNBC (18.1%), and Her2 (17%), with the highest stages being IIIB (31.7%). Conclusions: The breast cancer was presented at higher stage, with more cases with estrogen or progesterone receptors are positive with low frequency of Her2 positivity and high in Ki67 protein expression.http://www.waocp.com/journal/index.php/apjcc/article/view/550breast cancerindonesiaimmunohistochemistrysubtypesstaging
spellingShingle I Ketut Widiana
Hendry Irawan
Clinical and Subtypes of Breast Cancer in Indonesia
Asian Pacific Journal of Cancer Care
breast cancer
indonesia
immunohistochemistry
subtypes
staging
title Clinical and Subtypes of Breast Cancer in Indonesia
title_full Clinical and Subtypes of Breast Cancer in Indonesia
title_fullStr Clinical and Subtypes of Breast Cancer in Indonesia
title_full_unstemmed Clinical and Subtypes of Breast Cancer in Indonesia
title_short Clinical and Subtypes of Breast Cancer in Indonesia
title_sort clinical and subtypes of breast cancer in indonesia
topic breast cancer
indonesia
immunohistochemistry
subtypes
staging
url http://www.waocp.com/journal/index.php/apjcc/article/view/550
work_keys_str_mv AT iketutwidiana clinicalandsubtypesofbreastcancerinindonesia
AT hendryirawan clinicalandsubtypesofbreastcancerinindonesia